0 CHECKOUT

Analgesics in the United Arab Emirates

  • ID: 2477301
  • January 2016
  • Region: United Arab Emirates
  • 27 pages
  • Euromonitor International
1 of 3

Analgesics recorded 8% value growth in 2014, higher than the 6% value CAGR witnessed over the review period. The category is expected to enter the maturity phase from 2016 onwards, although in 2015 it recorded healthy growth due to the growing population and tourist flows into the country.

The Analgesics in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown
2 of 3

ANALGESICS IN THE UNITED ARAB EMIRATES

January 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2010-2015
Table 2 Sales of Analgesics by Category: % Value Growth 2010-2015
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2010-2015
Table 4 NBO Company Shares of Analgesics: % Value 2011-2015
Table 5 LBN Brand Shares of Analgesics: % Value 2012-2015
Table 6 Forecast Sales of Analgesics by Category: Value 2015-2020
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2015-2020
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 1 Julphar Gulf Pharmaceutical: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Julphar Gulf Pharmaceutical: Competitive Position 2015
Executive Summary
Consumer Health Records Healthy Growth in 2015
Government Initiatives Continue To Foster Consumer Health
Consumer Health Is Increasingly Important
Strong Consumer Preference for Branded Products Is Challenged
Chemists/pharmacies Retains Its Lead As the Primary Distribution Channel for Consumer Health
Key Trends and Developments
OTC Continues To Witness Healthy Growth in 2015, Driven by Government Initiatives To Raise Consumer Health Awareness
Self-medication Trends Remain Common Among Consumers
Press and Social Media Continue To Positively Impact Sales
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 9 Life Expectancy at Birth 2010-2015
Market Data
Table 10 Sales of Consumer Health by Category: Value 2010-2015
Table 11 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 12 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 13 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 14 Distribution of Consumer Health by Format: % Value 2010-2015
Table 15 Distribution of Consumer Health by Format and Category: % Value 2015
Table 16 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 3 Research Sources

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Baxter International Inc.
  • Endo International Plc.
  • Medtronic, Inc.
  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Purdue Pharma L.P.